| Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 248 | 2022 |
| Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction NB Abt, JM Flores, PA Baltodano, KA Sarhane, FM Abreu, CM Cooney, ... JAMA surgery 149 (10), 1068-1076, 2014 | 58 | 2014 |
| Cataract surgery outcomes in uveitis: the multicenter uveitis steroid treatment trial HN Sen, FM Abreu, TA Louis, EA Sugar, MM Altaweel, SG Elner, ... Ophthalmology 123 (1), 183-190, 2016 | 36 | 2016 |
| Economic growth and mortality: do social protection policies matter? U Bilal, R Cooper, F Abreu, C Nau, M Franco, TA Glass International journal of epidemiology 46 (4), 1147-1156, 2017 | 33 | 2017 |
| A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER) CD Austin, M Gonzalez Edick, RE Ferrando, M Solon, M Baca, K Mesh, ... Clinical & Experimental Allergy 50 (12), 1342-1351, 2020 | 31 | 2020 |
| YOSEMITE and RHINE: phase 3 randomized clinical trials of faricimab for diabetic macular edema: study design and rationale N Eter, RP Singh, F Abreu, K Asik, K Basu, C Baumal, A Chang, KG Csaky, ... Ophthalmology Science 2 (1), 100111, 2022 | 22 | 2022 |
| Preoperative anemia and postoperative outcomes in immediate breast reconstructive surgery: a critical analysis of 10,958 patients from the ACS-NSQIP database KA Sarhane, JM Flores, CM Cooney, FM Abreu, M Lacayo, PA Baltodano, ... Plastic and Reconstructive Surgery–Global Open 1 (5), e30, 2013 | 19 | 2013 |
| Preoperative radiotherapy is not associated with increased post-mastectomy short-term morbidity: analysis of 77,902 patients PA Baltodano, ME Reinhardt, JM Flores, FM Abreu, A Chattha, L Kone, ... Plastic and Reconstructive Surgery–Global Open 5 (3), e1108, 2017 | 11 | 2017 |
| Efficacy, durability, and safety of faricimab in diabetic macular edema (DME): One-year results from the phase 3 YOSEMITE and RHINE trials JA Wells, CC Wykoff, JR Willis, Z Haskova, H Lin, D Silverman, ... Investigative Ophthalmology & Visual Science 62 (8), 1037-1037, 2021 | 9 | 2021 |
| BALATON and COMINO: phase III randomized clinical trials of faricimab for retinal vein occlusion: study design and rationale LO Hattenbach, F Abreu, P Arrisi, K Basu, CJ Danzig, R Guymer, ... Ophthalmology Science 3 (3), 100302, 2023 | 8 | 2023 |
| Faricimab in RVO: Results from the BALATON and COMINO phase 3 studies R Tadayoni, LP Paris, F Abreu Angiogenesis, Exudation and Degeneration, 10-11, 2023 | 6 | 2023 |
| Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group. Cataract surgery outcomes in Uveitis: the multicenter Uveitis steroid treatment trial HN Sen, FM Abreu, TA Louis, EA Sugar, MM Altaweel, SG Elner, ... Ophthalmology 123 (1), 183-190, 2016 | 5 | 2016 |
| Personalized treatment interval (PTI) dosing dynamics over 2 years in the phase 3 YOSEMITE and RHINE trials of faricimab in diabetic macular edema CR Baumal, J Kitchens, G Jaffe, BS Gerendas, F Abreu, K Asik, A Camino, ... Investigative Ophthalmology & Visual Science 63 (7), 3851-3851, 2022 | 2 | 2022 |
| Nasal biomarkers characterization in lebrikizumab bronchoscopy study (CLAVIER) F Cai, F Abreu, HT Ding, D Choy, M Bremer, T Staton, R Erickson, K Peng, ... Journal of Allergy and Clinical Immunology 141 (2), AB118, 2018 | 2 | 2018 |
| Neoadjuvant radiotherapy is not associated with increased post-mastectomy/reconstruction morbidity events: A critical analysis of 85,851 patients from the ACS-NSQIP database PA Baltodano, JM Flores, L Kone, NB Abt, KA Sarhane, DH Rochlin, ... Plastic and Reconstructive Surgery 133 (3S), 135-136, 2014 | 2 | 2014 |
| Building a clinical risk model to predict morbidity after breast surgery KA Sarhane, JM Flores, FM Abreu, Z Ibrahim, M Alrakan, CM Cooney, ... Journal of the American College of Surgeons 217 (3), S89, 2013 | 1 | 2013 |
| Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials R Tadayoni, LP Paris, CJ Danzig, F Abreu, AM Khanani, C Brittain, ... Ophthalmology, 2024 | | 2024 |
| Efficacy, Durability, and Safety of Faricimab in Patients From Asian Countries With Diabetic Macular Edema: 1-Year Subgroup Analysis of the Phase III YOSEMITE and RHINE Trials S Ishida, SJ Chen, T Murata, Y Ogura, P Ruamviboonsuk, T Sakamoto, ... The Asia-Pacific Journal of Ophthalmology 12 (5), 451-459, 2023 | | 2023 |
| Durable vision gains and greater fluid control with extended faricimab dosing vs aflibercept in patients with DME JI Lim, SJ Chen, N Steinle, GJ Jaffe, BS Gerendas, F Abreu, A Camino, ... Investigative Ophthalmology & Visual Science 64 (8), 2815-2815, 2023 | | 2023 |
| Design and rationale of the YOSEMITE and RHINE trials: two phase 3 studies of faricimab in patients with diabetic macular edema N Eter, JR Willis, CQ Ruiz, F Abreu, H Lin, D Silverman, J Ives, K Basu, ... Investigative Ophthalmology & Visual Science 62 (8), 1043-1043, 2021 | | 2021 |
Karim SarhaneJohns Hopkins University, University of Toledo, Burjeel Royal HospitalVerified email at jhu.edu
